Corbus Pharmaceuticals Holdings, Inc.CRBPNASDAQ
LOADING
|||
Switch Symbol:
EPS Growth Under Pressure
Trending lower, above historical average, modest growth trend.
Left:
||||
Year-over-year earnings per share growth rate
Latest
-31.94%
↑ 27% above average
Average (39q)
-44.03%
Historical baseline
Range
High:107.05%
Low:-1172.22%
CAGR
+6.7%
Consistent expansion
| Period | Value |
|---|---|
| Q3 2025 | -31.94% |
| Q2 2025 | -3.60% |
| Q1 2025 | -78.21% |
| Q4 2024 | 32.17% |
| Q3 2024 | 67.61% |
| Q2 2024 | -44.90% |
| Q1 2024 | -35.36% |
| Q4 2023 | 20.26% |
| Q3 2023 | -10.73% |
| Q2 2023 | 51.65% |
| Q1 2023 | -61.83% |
| Q4 2022 | -21.86% |
| Q3 2022 | 63.93% |
| Q2 2022 | -124.06% |
| Q1 2022 | -8.13% |
| Q4 2021 | -373.08% |
| Q3 2021 | 88.24% |
| Q2 2021 | -6.76% |
| Q1 2021 | -39.86% |
| Q4 2020 | 76.86% |
| Q3 2020 | 17.32% |
| Q2 2020 | -20.48% |
| Q1 2020 | -4.14% |
| Q4 2019 | -27.77% |
| Q3 2019 | -1172.22% |
| Q2 2019 | 107.05% |
| Q1 2019 | -40.68% |
| Q4 2018 | -18.41% |
| Q3 2018 | -21.01% |
| Q2 2018 | -1.77% |
| Q1 2018 | -4.36% |
| Q4 2017 | -43.27% |
| Q3 2017 | 4.59% |
| Q2 2017 | 9.73% |
| Q1 2017 | 5.66% |
| Q4 2016 | -39.89% |
| Q3 2016 | -12.96% |
| Q2 2016 | -40.26% |
| Q1 2016 | -16.08% |
| Q4 2015 | -2.58% |